Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
AIM ImmunoTech Inc. (AIM) had Return on Tangible Equity of -62.82% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.03M |
|
$-3.79M |
|
$0.01M |
|
$0.02M |
|
$3.54M |
|
$-3.51M |
|
$-0.28M |
|
$-3.79M |
|
$-3.79M |
|
$-3.79M |
|
$-3.79M |
|
$-3.79M |
|
$-3.79M |
|
$-3.51M |
|
$-3.14M |
|
17.12M |
|
17.12M |
|
$-0.43 |
|
$-0.43 |
|
| Balance Sheet Financials | |
$10.43M |
|
$0.05M |
|
$2.30M |
|
$12.73M |
|
$4.95M |
|
-- |
|
$0.04M |
|
$4.99M |
|
$7.74M |
|
$6.03M |
|
$7.74M |
|
28.99M |
|
| Cash Flow Statement Financials | |
$-7.31M |
|
$-0.15M |
|
$14.37M |
|
$2.98M |
|
$9.90M |
|
$6.92M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.11 |
|
-- |
|
-- |
|
-- |
|
0.47 |
|
80.77% |
|
-13511.54% |
|
-13511.54% |
|
-- |
|
-14569.23% |
|
-14569.23% |
|
$-7.31M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-48.92% |
|
|
Return on Tangible Equity |
-62.82% |
-29.75% |
|
-48.92% |
|
$0.27 |
|
$-0.43 |
|
$-0.43 |
|